Editorial: stratifying risk of adverse outcomes in cirrhosis-the Hepquant SHUNT test. Authors' reply

Aliment Pharmacol Ther. 2021 Apr;53(8):941-942. doi: 10.1111/apt.16311.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fistula*
  • Humans
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / diagnosis